openPR Logo
Press release

Prenatal and New-born Genetic Testing Market to Rake in Nearly US$8.37 bn In Terms of Revenue By the End of 2019

12-06-2017 02:14 PM CET | Health & Medicine

Press release from: Transparency Market Research

Prenatal and New-born Genetic Testing Market to Rake in Nearly

The global prenatal and newborn genetic testing market is progressing at a CAGR of 26.9% within a forecast period of 2013 to 2019. The market was valued at US$1.20 bn in 2012. By the end of 2019, this market will be valued at US$8.37 bn, according to a research report released by Transparency Market Research. The report is titled “Prenatal and New-born Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” and provides an estimate for the market’s future using time-tested methods for market analysis. The report is available for sale on the company website, and offers key details on the market through a segmented manner of research.

Read Report Overview @

Prenatal and newborn genetic testing refers to the use of a certain set of screening procedures that can detect abnormalities in the chromosomes of a child or a fetus. The tests can be used in 8 to 10 weeks of gestation. They can help detect genetic diseases such as Edward Syndrome, Patau Syndrome, and Down syndrome.

According to the report, the global prenatal and newborn genetic testing market is primarily driven by the high number of women opting for late childbirth. This increase in the average maternal age as well as late pregnancies is boosting the global prenatal and newborn genetic testing market to adopt faster and more efficient technologies. Another driver for this market is the increasing rate of awareness among individuals regarding the benefits of conducting prenatal genetic testing. The global prenatal and newborn genetic testing market can successfully help a parent detect whether their newborn or a fetus has any genetic disorders.

There is a subtle increase in the number of newborns being diagnosed with genetic defects. This is causing expectant mothers to opt for genetic testing early on in order to diagnose and cure any such defects. The Northwestern Medical Faculty Foundation had previously stated that a majority of women, both with newborns and those who are pregnant, are choosing genetic screening of their fetus or child in the United States.

The report provides details on the global prenatal and newborn genetic testing market with a segmented approach, with technology and geography being the key criteria. In terms of diagnostic tests, a sub-segment of technology, the global prenatal and newborn genetic testing market was led by PCR in 2012, owing to its high rate of success, procedural simplicity, and accuracy.

The other sub-segment of technology is screening tests, and it was led by NIPT in 2012. NIPT is also expected to be the fastest-growing segment for the given forecast period – a 37.60% CAGR between 2013 and 2019.

Geographically speaking, the global prenatal and newborn genetic testing market was led by North America in 2013 owing to the high popularity of NIPT as it is noninvasive. At the same time, a rapidly growing rate of awareness in Asia Pacific has helped this region achieve the fastest growth rate in the market for the given forecast period.

Key players in the global prenatal and newborn genetic testing market are Sequenom, Inc., PerkinElmer, Inc., Natera, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., Bio-Rad Laboratories, Inc., Ariosa Diagnostics, Inc., and Agilent Technologies, Inc.

Request Sample Report @

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prenatal and New-born Genetic Testing Market to Rake in Nearly US$8.37 bn In Terms of Revenue By the End of 2019 here

News-ID: 848298 • Views: 171

More Releases from Transparency Market Research

Osteoporosis Drugs Market Companies Analysis, Advancement and Precise Outlook …
Transparency Market Research (TMR) has published a new report titled, ‘Osteoporosis Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Osteoporosis Drugs market was valued at US$ 11.5 Bn in 2018 and is projected to contract at a CAGR of 0.3% from 2019 to 2027. Overview Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to
Remote Patient Monitoring Devices Market News Research Report 2020
The global remote patient monitoring devices market is foreseen in a report by Transparency Market Research (TMR) to show a decently consolidated nature coupled with intense competition between key players. Recently, a larger aggregate share was held by a few prominent names of the market. F. Hoffmann-La Roche Ltd., AMD Global Telemedicine, and Honeywell HomMed LLC are some of the leading companies operating in the market. Merger and acquisition could
Oxygen Therapy Devices Market is Thriving Worldwide By Size, Revenue, Emerging T …
The demand within the global oxygen therapy devices market is projected to increase as improved medical procedures make their way into the healthcare industry. Towards the end of last year, a group of high-school students became victims of gas poisoning across a large building in Suwon. The absence of proper medical equipment for oxygen therapy became a matter of regional outrage. In this review, Transparency Market Research (TMR) looks into
Covid-19 Impact on Organic Turmeric Market: Present Scenario and Future Growth P …
The report details an exhaustive account of the global organic turmeric market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2026. From an overall perspective, the report is expected to exist as a valuable insight

All 5 Releases

More Releases for Prenatal

Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ The global prenatal diagnostics market is segmented on
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
The presence of a large number of companies has rendered the global prenatal vitamin supplements market highly competitive. According to a new study by Transparency Market Research (TMR), Garden of Life, Inc., Country Life LLC., Rainbow Light Nutritional System, Inc., Church & Dwight Co., Inc., and Biotics Research Corporation are among the leading companies in the global prenatal vitamin supplements market. Besides product development, a majority of the leading names
Prenatal Vitamin Supplements Market
“The global prenatal vitamin supplements market is expected to gain momentum as leading players forge strategic partnerships,” said a lead TMR analyst. As companies collaborate into a joint venture, they are primarily aiming at introducing brands to customers around the world and development of new products. Spurred by this, the global prenatal vitamin supplements market is forecast to exhibit strong growth between 2016 and 2024. The presence of a large number
Non Invasive Prenatal Testing Market Report 2017
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also
Global Non Invasive Prenatal Testing Market
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow at the CAGR
Prenatal Vitamin Preparation Market Expected to Dominate Worldwide by 2026
Prenatal vitamin are prescribed during pregnancy and postnatal lactation. Prenatal vitamins comprises of a variety of vitamins and minerals that help baby get nutrients that are essential for healthy growth. Minerals and vitamins such as folic acid, iron and calcium are vital for proper fetal growth and development. Currently, in the US, all obstetricians recommend pregnant women to take prenatal vitamins to avoid and reduce birth defects. Prenatal vitamin also